Yajuan Liu PhD

genomics/genetics , evolution , phylogenetics , mutation , gene duplication , microarrays , sequencing (RNAseq, exome, ChIP, WGS) , personalized medicine , heredity , diagnosis , prognosis , treatments (intervention)


Dr. Liu's research lab is currently focused on the following four projects: (1)Developing DNA sequence-based characterization of breakpoints of chromosome translocations/inversions in cancer using next generation sequencing. (2) Identifying new markers for Hepatitis C-associated hepatocellular carcinoma. (3) Correlating genetic alterations detected using genomic microarray and next generation sequencing with histology and clinical outcome in melanocytic neoplasms. (4) Use of genomic microarray analysis to rule in/out oncocytoma of the kidney in needle core biopsies. Dr. Liu's main goals are to identify cancer biomarkers and novel therapeutic targets and to develop molecular diagnostics using both conventional genetics methods and new genomic approaches to aid in precision diagnostics for personalized care.


University of Washington School of Medicine Pathology Associate Professor